Clinical Trials Directory

Trials / Conditions / IPMN, Pancreatic

IPMN, Pancreatic

12 registered clinical trials studyying IPMN, Pancreatic — 9 currently recruiting.

StatusTrialSponsorPhase
RecruitingAI-Powered Precision Decision-Making for Pancreatic Diseases
NCT07439757
Changhai Hospital—
RecruitingPreventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Ap
NCT07262957
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 4
Not Yet RecruitingImpact of GLP-1 Receptor Agonists on Patients With IPMN
NCT07014709
Hôpital Fribourgeois—
RecruitingIdentification of New Theranostic Biomarkers of Pancreatic Tumor Progression
NCT06574373
Fondazione Policlinico Universitario Agostino Gemelli IRCCS—
RecruitingIntegration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bI
NCT06694792
IRCCS San Raffaele—
Enrolling By InvitationThe LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)
NCT06276764
Adenocyte, LLC—
Active Not RecruitingStudy of IPMN Progression Prevention With Tocotrienol (SIPP-T3)
NCT06519097
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
Enrolling By InvitationPancreatic Cancer Initial Detection Via Liquid Biopsy
NCT06283576
Karolinska University Hospital—
UnknownA Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous Neoplasm
NCT05593393
Peking Union Medical College Hospital—
RecruitingIntraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer
NCT05117723
St Vincent's Hospital Melbourne—
Active Not RecruitingThe Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
NCT04207944
Duke UniversityPhase 2
RecruitingAdvanced Therapies for Liver Metastases
NCT04622423
IRCCS San Raffaele—